About Us

About SDIX

SDIX is a wholly owned subsidiary of OriGene Technologies, specializing in high quality, large-scale GMP antibody production in the U.S, Delaware and Maine.

For over 30 years, SDIX has been a leading immuno-solutions company, developing results-oriented and innovative antibody-based solutions that enable customers, world-wide, to meet high performance diagnostic and commercialization objectives. All sites are ISO 13485:2016 certified.

Products include critical reagents such as antibodies to Troponin I, Strep A, CRP, Apo A1, ApoB, Micro-albumin and Calibrators. SDIX’s services include Polyclonal Development and production in a variety of species as well as large-scale Monoclonal Antibody Production (ascites and in vitro).

 

Element

Become a Member


Continue

By continuing to use this site you agree to the use of cookies

SDIX uses cookies to improve your experience on the website and to provide you with services and content tailored to your interests

Learn more about The SDIX Cookie Policy

Learn more about The SDIX Privacy Policy

You have Successfully Subscribed!